13F Insight
DOSSIER · 13F-HR · Q2 2026

AlphaCentric Advisors LLC

$118M in tracked AUM across 261 positions as of Q2 2026.

AA
CIK 0001913464 · last filed Jun 30, 2026
Total AUM
$118M
as of Q2 2026
Holdings
261
—
positions
Whale Score
41
41
tracked
Activity
—
no data
changes this Q
AI Analysis · Q2 2026

AlphaCentric Advisors LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
GILD
GILEAD SCIENCES INC
$3M20K2.2%02
VRTX
VERTEX PHARMACEUTICALS INC
$2M5K2.1%03
INVH
INVITATION HOMES INC
$2M73K1.9%04
G0593M107
ASTRAZENECA PLC
$2M11K1.8%05
G76279101
ROIVANT SCIENCES LTD
$2M48K1.4%06
ARGX
ARGENX SE
$2M2K1.4%07
NBIX
NEUROCRINE BIOSCIENCES INC
$2M10K1.4%08
INCY
INCYTE CORP
$2M14K1.4%09
AXSM
AXSOME THERAPEUTICS INC.
$2M7K1.4%10
APGE
APOGEE THERAPEUTICS INC
$2M12K1.3%

Filing history

2026Q2Jun 30
$118M▲ 17.8%
261 positionsView →2025Q4Dec 31
$100M▲ 0.0%
250 positionsView →2024Q4Dec 31
$100M▼ 25.5%
212 positionsLocked2024Q3Sep 30
$135M▼ 0.9%
231 positionsLocked2024Q2Jun 30
$136M▼ 18.1%
218 positionsLocked2024Q1Mar 31
$166M▲ 11.3%
228 positionsLocked2023Q4Dec 31
$149M▼ 15.5%
216 positionsLocked2023Q3Sep 30
$176M▼ 2.2%
235 positionsLocked2023Q2Jun 30
$180M▲ 24.4%
233 positionsLocked2023Q1Mar 31
$145M▲ 43.2%
209 positionsLocked2022Q4Dec 31
$101M▲ 103764.1%
165 positionsLocked2022Q3Sep 30
$97K▼ 100.0%
185 positionsLocked
Showing 12 of 19